TOP activity is related to increased degradation of the Aβ peptide, the component of amyloid plaques in Alzheimer's disease produced by the degradation of the APP (amyloid precursor protein) 8, 19. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.